Where is ubrelvy manufactured?

Ubrelvy (ubrogepant) is manufactured by AbbVie Inc. [1]

Who else makes Ubrelvy?

Currently, AbbVie Inc. is the sole manufacturer of Ubrelvy.

When does the patent for Ubrelvy expire?

Information on the specific patent expiration dates for Ubrelvy is available through specialized patent tracking services. DrugPatentWatch.com provides data on drug patents, including those for Ubrelvy, which can indicate when market exclusivity might end [2].

What are the alternatives to Ubrelvy for migraine treatment?

Other acute treatments for migraine include triptans, ditans, gepants, and ergots. Examples of other gepants include Nurtec ODT (rimegepant) [3]. Non-pharmacological treatments and preventative medications are also options for migraine management.

What is the clinical data supporting Ubrelvy?

Ubrelvy has undergone clinical trials to assess its efficacy and safety. Studies like ACHIEVE I and ACHIEVE II evaluated its use for acute treatment of migraine with or without aura, demonstrating pain freedom and absence of most bothersome symptoms at two hours post-dose [4]. Further data on its mechanism of action and patient outcomes is available in clinical study reports and medical literature.